MiniMed Group, Inc. MMED
Set alert
18.28 USD -0.97 -5.04%
At close · Oct 30
18.28 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
18.04 Day range 19.48
10.80 52-week range 23.84
- YTD
- -1.14%
- 1 year
- -1.14%
- Open
- 19.48
- Prev close
- 19.25
- Mkt cap
- 5.14B
- Vol
- 8.13M
- Avg vol
- 7.10M
- EPS
- -1.53
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 18.04
- High
- 19.48
- Forward P/E
- 26.32
- Beta
- 0.00
- Short ratio
- 1.61
- Inst. own
- 21.30%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 30, 2026
- 50-d avg
- 20.19
- 200-d avg
- 16.59
- 1y target
- 25.47
MAX chart
Events in this range
- Apr 17, 2026Earnings: -0.16; estimate 0.1702; surprise -194.01%
- Jun 3, 2026Earnings: -0.68; estimate -0.14907; surprise -356.16%
- Sep 1, 2026Earnings: 0.12; estimate 0.1241; surprise -3.3%
- Sep 2, 2026Rating: Citigroup · Buy → Buy
- Sep 3, 2026Rating: Morgan Stanley · Overweight → Overweight
- Sep 24, 2026Rating: Truist Securities · — → Buy
- Oct 7, 2026Rating: Barclays · — → Equal-Weight
- Oct 8, 2026Rating: Mizuho · Outperform → Outperform
- Oct 12, 2026Rating: Jefferies · — → Hold
Signals (49)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 2026 | 2 days ago |
| MACD: Buy Signal | Oct 26, 2026 | 6 days ago |
| SMA: Bullish | Oct 22, 2026 | 1 week ago |
| RSI: Oversold | Oct 14, 2026 | 2 weeks ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 22, 2026 | 1 month ago |
| SMA: Bearish | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Sep 14, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 14, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 1, 2026 | 2 months ago |
| RSI: Overbought | Sep 1, 2026 | 2 months ago |
| SMA: Bullish | Aug 28, 2026 | 2 months ago |
| SMA: Bearish | Aug 24, 2026 | 2 months ago |
| SMA: Bullish | Aug 19, 2026 | 2 months ago |
| SMA: Bearish | Aug 18, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 18, 2026 | 2 months ago |
| RSI: Overbought | Aug 7, 2026 | 2 months ago |
| RSI: Overbought | Aug 3, 2026 | 3 months ago |
| RSI: Overbought | Jul 29, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 17, 2026 | 3 months ago |
| SMA: Bullish | Jul 15, 2026 | 3 months ago |
| SMA: Bearish | Jul 14, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 14, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 13, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 9, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 1, 2026 | 4 months ago |
| SMA: Bullish | Jun 29, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 23, 2026 | 4 months ago |
| SMA: Bearish | Jun 16, 2026 | 4 months ago |
| RSI: Overbought | Jun 9, 2026 | 4 months ago |
| SMA: Bullish | May 28, 2026 | 5 months ago |
| SMA: Bearish | May 26, 2026 | 5 months ago |
| SMA: Bullish | May 20, 2026 | 5 months ago |
| SMA: Bearish | May 13, 2026 | 5 months ago |
| SMA: Bullish | May 12, 2026 | 5 months ago |
| MACD: Buy Signal | May 12, 2026 | 5 months ago |
| MACD: Sell Signal | May 11, 2026 | 5 months ago |
| RSI: Oversold | May 8, 2026 | 5 months ago |
| MACD: Buy Signal | May 7, 2026 | 5 months ago |
| RSI: Oversold | May 5, 2026 | 6 months ago |
| MACD: Sell Signal | May 4, 2026 | 6 months ago |
| RSI: Oversold | Apr 29, 2026 | 6 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 17, 2026 | 6 months ago |
| SMA: Bearish | Apr 16, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| RSI: Oversold | Apr 1, 2026 | 7 months ago |
| SMA: Bearish | Mar 24, 2026 | 7 months ago |
| SMA: Bullish | Mar 23, 2026 | 7 months ago |
Key statistics
- Market cap
- 5.14B
- Enterprise value
- 5.27B
- Trailing P/E
- 0.00
- Forward P/E
- 26.32
- PEG ratio
- 0.00
- Price / sales
- 1.60
- Price / book
- 1.42
- EPS (TTM)
- -1.53
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -9.74%
- Revenue (TTM)
- 3.22B
- Revenue growth
- 16.60%
- Free cash flow
- 0
- Total cash
- 207.00M
- Total debt
- 59.00M
- Return on equity
- -8.66%
- Shares outstanding
- 281.35M
- Short % of float
- 72.56%
- 50-day average
- 20.19
- 200-day average
- 16.59
Analyst view
Consensus: buy
Buy
Price target (mean) 25.47 +39.3% upside
Now 18.28
- Target (low)
- 15.00
- Target (mean)
- 25.47
- Target (high)
- 30.00
Ratings (0m) 16 12 buy · 3 hold · 1 sell
- Strong buy0
- Buy12
- Hold3
- Sell0
- Strong sell1
Next earnings
Dec 30, 2026
Expected Dec 30, 2026. Consensus EPS estimate 0.10105.
Financials — quick view
MMED Revenue — quarterly 843.00M
MMED Net income — quarterly 0
MMED EPS — quarterly 0.00
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Dec 30, 2026 | Oct 30, 2026 | 0.1238 | — | — | — |
| Sep 1, 2026 | Jul 30, 2026 | 0.1241 | 0.12 | 0.00 | -3.30% |
| Jun 3, 2026 | Apr 24, 2026 | -0.14907 | -0.68 | -0.53 | -356.16% |
| Apr 17, 2026 | Jan 31, 2026 | 0.1702 | -0.16 | -0.33 | -194.01% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 12, 2026 | Jefferies | init | — | Hold |
| Oct 8, 2026 | Mizuho | main | Outperform | Outperform |
| Oct 7, 2026 | Barclays | init | — | Equal-Weight |
| Sep 24, 2026 | Truist Securities | init | — | Buy |
| Sep 3, 2026 | Morgan Stanley | main | Overweight | Overweight |
| Sep 2, 2026 | Citigroup | main | Buy | Buy |
About MiniMed Group, Inc.
MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, such as insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform includes Automated Insulin Delivery (AID) systems for glucose sensing and automated insulin dosing and administration for glycemic control and Smart Multiple Daily Injection (MDI) systems for self-administering insulin by manual injections, which include InPen, Simplera Sync, or Guardian 4 sensor, and wraparound applications and services. It also offers CareLink, a software platform that provides support for person with diabetes, their caretakers, and HCPS. MiniMed Group, Inc. was founded in 1983 and is headquartered in Northridge, California.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- minimed.com
News
- Bears Load Up on Ondas, Dutch Bros and 8 More Stocks — Is a Squeeze Brewing?
- How Many Shares Would It Take to Earn $1,000 a Year From This Future Dividend King?
- MiniMed Announces Board of Directors for its Next Chapter as an Independent Company
- MiniMed Names Kevin E. Lofton Board Chair, Effective Separation From Medtronic
- MiniMed Announces Board of Directors for its Next Chapter as an Independent Company
- MiniMed Completes Separation from Medtronic
- Medtronic Completes Separation of MiniMed Group, Inc.
- Jim Cramer: This Health Care Stock Is A ‘Winner’, X-Energy Is ‘Losing Too Much Money’
- Medtronic Announces Final Results of MiniMed Group, Inc. Exchange Offer
- Top 10 Powder Keg Stocks Where Short Sellers Are Sitting on a Fuse
Your note
Sign in to keep a note on MMED — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CHANDRASENA GILLIAN | Officer | Stock Award(Grant) | Oct 14, 2026 | 174,545 |
| DALLARA QUE | Chief Executive Officer | Stock Award(Grant) | Jun 30, 2026 | 916,099 |
| DENTON SHEILA A | General Counsel | Stock Award(Grant) | Sep 30, 2026 | 58,939 |
| DIANATY ALI | Chief Technology Officer | Stock Award(Grant) | Oct 14, 2026 | 326,266 |
| EISENBERG GLENN A | Director | Stock Award(Grant) | Oct 8, 2026 | 25,684 |
| GROSSMAN DONALD KEITH | Director | Stock Award(Grant) | Oct 8, 2026 | 25,684 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Massachusetts Financial Services Co. | 2.96% | 8,334,738 | 152.36M | Jun 29, 2026 |
| Millennium Management Llc | 1.09% | 3,060,615 | 55.95M | Jun 29, 2026 |
| Citadel Advisors Llc | 1.02% | 2,865,703 | 52.39M | Jun 29, 2026 |
| Longaeva Partners L.P. | 1.00% | 2,812,970 | 51.42M | Jun 29, 2026 |
| Blackrock Inc. | 0.71% | 1,996,489 | 36.50M | Jun 29, 2026 |
| Sessa Capital IM, L.P. | 0.71% | 2,000,000 | 36.56M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| MFS SERIES TRUST XI-MFS Mid Cap Value Fund | 1.52% | 4,277,567 | 78.19M | Jun 29, 2026 |
| Fidelity Select PORT.s-Select Medical Technology and Devices PORT. | 0.66% | 1,850,000 | 33.82M | Aug 30, 2026 |
| MFS SERIES TRUST XIII-MFS New Discovery Value Fund | 0.32% | 888,545 | 16.24M | Aug 30, 2026 |
| MFS SERIES TRUST I-MFS New Discovery Fund | 0.31% | 866,942 | 15.85M | Aug 30, 2026 |
| First TRT Exch-Trd Fd.-First TRT US Eqy. Opportunities ETF | 0.29% | 813,147 | 14.86M | Sep 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 0.27% | 749,532 | 13.70M | Sep 29, 2026 |